• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Dextromethorphan Hydrobromide Hydrate

Dextromethorphan Hydrobromide Hydrate

Product ID D1792
Cas No. 6700-34-1
Purity ≥98%
Product Unit SizeCostQuantityStock
5 g $68.70 In stock
10 g $120.20 In stock
50 g $469.20 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Dextromethorphan exhibits anti-tussive, hallucinogenic, neuromodulatory, neuroprotective, anticonvulsant/antiepileptic, and anti-osteoporotic activities. Dextromethorphan acts as a full antagonist at serotonin transporters (SERTs), norepinephrine transporters (NETs), α3β4, α4β2, and α7 nicotinic acetylcholine receptors (nAChRs), and NADPH oxidase; it also acts as a weak antagonist at NMDA receptors. Additionally, dextromethorphan acts as a full agonist at σ1/2 receptors and as a weak agonist at μ/κ/δ opioid receptors. Dextromethorphan is commonly used in over-the-counter cough medicines. In animal models of Parkinson’s disease, dextromethorphan inhibits endotoxin-induced dopaminergic neurodegeneration. In electroshock assays, this compound inhibits the development of seizures. Dextromethorphan also inhibits RANKL-induced osteoclastogenesis and prevents bone loss in vivo.

Product Info

Cas No.

6700-34-1

Purity

≥98%

Formula

C18H25NO • HBr • H2O

Formula Wt.

370.3

Chemical Name

D-(+)-3-methoxy-17-methyl- (9α,13α,14α)- morphinan

IUPAC Name

(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;hydrate;hydrobromide

Synonym

( )-3-Methoxy-N-methylmorphinon, delta-Methorphan

Melting Point

116-120°C

Solubility

Soluble in water (15 mg/mL).

Appearance

White powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

D1792 MSDS PDF

Info Sheet

D1792 Info Sheet PDF

References

Burns JM, Boyer EW. Antitussives and substance abuse. Subst Abuse Rehabil. 2013 Nov 6;4:75-82. PMID: 24648790.

Wu K, Lin TH, Liou HC, et al. Dextromethorphan inhibits osteoclast differentiation by suppressing RANKL-induced nuclear factor-κB activation. Osteoporos Int. 2013 Aug;24(8):2201-14. PMID: 23400250.

Damaj MI, Flood P, Ho KK, et al. Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. J Pharmacol Exp Ther. 2005 Feb;312(2):780-5. PMID: 15356218.

Zhang W, Wang T, Qin L, et al. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J. 2004 Mar;18(3):589-91. PMID: 14734632.

Chou YC, Liao JF, Chang WY, et al. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Res. 1999 Mar 13;821(2):516-9. PMID: 10064839.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • W9600

    WZ-4002

    EGFR (T790M) inhibitor.

    ≥98%
  • X4424

    XL-765

    PI3K and mTOR inhibitor.

    ≥98%
  • D5611

    Docosahexaenoic Acid (all cis-4,7,10,13,16,19) Methyl Ester

    Essential fatty acid found in fish oil, involve...

    ≥99%
  • A5334

    Anisodamine

    Tropane alkaloid found in Solanaceae plants; α...

    ≥97%
  • R3205

    Ribavirin

    Purine nucleoside analog; DNA chain terminator....

    ≥98%
  • A965121

    AZD-5438

    Inhibitor of CDK.

    ≥98%
  • M5746

    Molsidomine

    NO donor; annexin A2 inhibitor.

    ≥98%
  • B9200

    BX-795

    PDK1 inhibitor.

    ≥98%
  • N3225

    Nigericin Sodium

    Polyether cationic ionophore.

    ≥98%
  • P2845

    Phleomycin

    Glycopeptide, metal ion chelator, induces DNA s...

    ≥97%
  • C9881

    Cytochalasin D

    Mycotoxin produced by Aspergillus; actin polyme...

    ≥98%
  • C6818

    Crenolanib

    FLT3, PDGFR inhibitor.

    ≥98%
  • P005095

    N-Debenzoylpaclitaxel

    Paclitaxel derivative

    ≥95%
  • G7340

    GSK-126

    EZH2 HMT inhibitor.

    ≥98%, ≥99%ee
  • L582694

    Lorlatinib

    Third generation macrocyclic ALK inhibitor.

    ≥98%
  • P0010

    Pituitary Adenylate Cyclase-activating Polypeptide-related Peptide, human

    Peptide, involved in paracrine and autocrine ce...

    ≥95%
  • I7659

    1-Isothiocyanato-8-(methylsulfonyl)-octane

    ITC, erysolin analog.

    ≥98%
  • D3304

    Dibenzoylmethane, 98%

    Aromatic 1,3-diketone acetylacetone derivative ...

    ≥98%
  • I058584

    Ibotenic Acid

    Analog of glutamate

    ≥98%
  • A9710

    AZD-2014

    mTOR inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only